Northwest Clinical Center for Type 1 Diabetes - TrialNet

描述（由申请人提供）：本申请重新选择为糖尿病试验网临床中心，包括一份领导声明，概述了我们应对试验网当前挑战的观点和方法。它还描述了我们的临床中心目前和计划的活动，以完成TrialNet的使命，包括创新的方法来协作和有效地实现我们的总体目标-延迟和预防临床1型糖尿病的发病。TrialNet西北临床中心招募区域包括阿拉斯加、华盛顿、俄勒冈、爱达荷和蒙大拿州。我们与十几个附属网站、当地和区域T1D倡导组织以及糖尿病保健提供者合作，以确保T1D患者意识到他们的亲属有患病风险，并且可以通过TrialNet进行筛查和预防试验。我们还大力利用数字媒体进行招聘，包括使用网站、Facebook、Twitter来传递信息和促进讨论。我们地区有超过7500人接受了风险筛查。TrialNet西北临床中心的团队成员是TrialNet网络的积极参与者和领导角色。我们计划在新的试验网框架内合作，预防或延缓1型糖尿病。

DESCRIPTION (provided by applicant): This application for re-selection as a Diabetes TrialNet Clinical Center consists of a leadership statement outlining our perspective and approach to address TrialNet's current challenges. It also describes our Clinical Center's current and planned activities to accomplish TrialNet's mission including innovative approaches to collaboratively and efficiently achieving our overarching goal - delaying and preventing the onset of clinical type 1 diabetes. The TrialNet Northwest Clinical Center recruitment region encompasses Alaska, Washington, Oregon, Idaho, and Montana. We work with more than a dozen Affiliate sites, local and regional T1D advocacy groups and diabetes health care providers to assure that those with T1D are aware that their relatives are at risk for disease and that screening along with the possibility of prevention trials through TrialNet are available. We also have significant recruitment efforts using digital media, including the use of websites, Facebook, Twitter, to convey information and foster discussion. More than 7500 individuals in our region have been screened for risk. TrialNet Northwest Clinical Center team members are active participants and are in leadership roles in the TrialNet network. We plan to work collaboratively within the new TrialNet structure to prevent or delay type 1 diabetes.